Literature DB >> 6335003

Dose requirements of ICI 35,868 (propofol, 'Diprivan') in a new formulation for induction of anaesthesia.

G C Cummings, J Dixon, N H Kay, J P Windsor, E Major, M Morgan, J W Sear, A A Spence, D K Stephenson.   

Abstract

In order to avoid Cremophor-related reactions and reduce the incidence of pain on injection, diisopropylphenol (ICI 35,868; propofol) has been reformulated as an emulsion. One hundred and fifteen patients received an induction dose of propofol in the new formulation. The dose required to induce anaesthesia in 95% of healthy, unpremedicated patients was 2.5 mg/kg. Induction was associated with a degree of cardiovascular and respiratory depression. There were no adverse reactions although there were a number of minor side-effects. The incidence of pain on injection was low (3%) and the overall quality of induction was assessed as good or adequate in 92% of patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6335003     DOI: 10.1111/j.1365-2044.1984.tb06425.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  17 in total

Review 1.  Propofol: a sedative-hypnotic anesthetic agent for use in ambulatory procedures.

Authors:  D M Steinbacher
Journal:  Anesth Prog       Date:  2001

2.  Bayesian probabilistic network modeling of remifentanil and propofol interaction on wakeup time after closed-loop controlled anesthesia.

Authors:  Ulrich Bothtner; Stewart E Milne; Gavin N C Kenny; Michael Georgieff; Stefan Schraag
Journal:  J Clin Monit Comput       Date:  2002-01       Impact factor: 2.502

3.  Cyclosporine-vecuronium interaction.

Authors:  G G Wood
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

4.  Propofol infusion anaesthesia for caesarean section.

Authors:  M A Gregory; T Gin; G Yau; R K Leung; K Chan; T E Oh
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

Review 5.  Propofol: a review of its role in pediatric anesthesia and sedation.

Authors:  Vidya Chidambaran; Andrew Costandi; Ajay D'Mello
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

6.  Comparative evaluation of propofol and thiopentone for total intravenous anaesthesia.

Authors:  H Kashtan; G Edelist; J Mallon; D Kapala
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

7.  Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection.

Authors:  C A Knibbe; H J Voortman; L P Aarts; P F Kuks; R Lange; H J Langemeijer; M Danhof
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

8.  Pilot study in humans on the pharmacokinetics and safety of propofol 6% SAZN.

Authors:  C A Knibbe; V S Koster; L P Aarts; H J Langemeijer; M Danhof
Journal:  Pharm World Sci       Date:  1999-10

Review 9.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 10.  Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic.

Authors:  M S Langley; R C Heel
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.